← Leaderboards
Elizabeth E Sweeney
Immunoblue, Llc
$834,147
Attributed
$1,734,960
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,734,960 · 3
By mechanism
R42$1,135,290 · 1
R41$599,670 · 2
Top collaborators
- Rohan Fernandes3 shared
- Alejandro V Villagra1 shared
Others in their field
Other Emerging Leaders on “Generations”
- Klaus Romero · Critical Path Institute$88,602,036
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Ted Ross · University Of Georgia$70,992,558
- Leonard Freedman · Leidos Biomedical Research, Inc.$65,130,757
- Scott Topper · Broad Institute, Inc.$60,777,399
- John Damon Chodera · Sloan-Kettering Inst Can Research$59,941,649
Research focus
GenerationsIn VivoCytotoxicityEnsureInstitutional Review BoardsIn VitroChimeric Antigen Receptor T CellsCytolysisEfficacy TestingEngineeringGlioblastomaImmunogenic Cell DeathInterferon Type IiAutoreactivityAntigensBedsAdjuvant TherapyClinical ResearchDendritic CellsDoseAutologousCellsAutologous Dendritic CellsManufacture
Grant awards (3)
Engineered Glioblastoma-specific T cells using Immunostimulatory Photothermal Nanoparticles$1,135,290
R42 · FY2025 · CA · contact PI
Engineered Glioblastoma-specific T cells using Immunostimulatory Photothermal Nanoparticles$399,669
R41 · FY2024 · CA · contact PI
An Engineered Nanoimmunotherapy for Melanoma$200,001
R41 · FY2018 · CA · contact PI